Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ANTA PHAR       

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat autoimmune diseases.The company's primary product candidate, blisibimod, targets elevated levels of B-cell activating factor, or BAFF, which has been associated with a... 
Sector
Pharmaceuticals
Calendar
03/24Earnings Release
More about the company
Financials ($)
Sales 2014 -
EBIT 2014 -29,3 M
Net income 2014 -30,8 M
Debt 2014 -
Yield 2014 -
Sales 2015 -
EBIT 2015 -37,4 M
Net income 2015 -38,8 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0
Capi. / Sales 2015 0
Capitalization 41,8 M
More Financials
Latest news on ANTA PHAR
1d ago ANTHERA PHARMACEUTICALS : to Present at Annual Piper Jaffray Healthcare Conferen..
3d ago ANTHERA PHARMACEUTICALS : Notice of Delisting or Failure to Satisfy a Continued ..
4d ago ANTHERA PHARMACEUTICALS : and Patheon Sign Manufacturing Agreement for Liprotama..
11/14 ANTHERA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
11/14 ANTHERA PHARMACEUTICALS : Results of Operations and Financial Condition (form 8-..
11/14 ANTHERA PHARMACEUTICALS : Reports 2014 Third Quarter Financial Results and Opera..
10/23 ANTHERA PHARMACEUTICALS : Termination of a Material Definitive Agreement (form 8..
10/08 ANTHERA PHARMACEUTICALS : Announces Update on Strategic Partnership Discussions ..
10/01 ANTHERA PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form ..
10/01 ANTHERA PHARMACEUTICALS : Announces Update on Strategic Partnership Discussions ..
08/14 ANTHERA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
08/06 ANTHERA PHARMACEUTICALS : Reports 2014 Second Quarter Financial Results and Oper..
More news
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF